The aim of the study was to study the antitumor activity of the new antitumor drug "colhametin" (K-2) on 2 tumor strains. Material and research methods. The study of antitumor activity was performed on 42 outbred and 34 strain mice with transplanted tumors Ehrlich's solid tumor (EST) and AKATOL, which were injected with drugs on the 4th day after tumor inoculation 10 times. The results were evaluated according to standard criteria: tumor growth inhibition (TGI), body weight and spleen weight of animals. Differences were considered significant at p<0.05. Results. The study of the activity of the new developed antitumor drug colhametin (K-2) revealed that the drug inhibits the growth of tumors: AKATOL by 94/91%, Erlikhan's solid tumor by 92/78%, more than 50% more active than colhamin and 9- 20% more active than taxol and etoposide. Conclusions. The studied substance can be submitted for clinical trials, as it meets the requirements for a promising anticancer drug, in addition, its activity is higher than the effect of drugs used for comparison.
| Mualliflar | YULDASHEV Zhovlon Abduraim-ugly, ABDUKHALILOV Majid Mamatkulovich, RAKHIMOV Nodir Maxammatkulovich, ENIKEEVA Zulfiya Makhmudovna, IBRAGIMOV Shavkat Narzikulovich |
|---|---|
| Jurnal | Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali |
| Nashriyot | Тошкент давлат стоматалогия институти, , «Expert Lawyers» MЧЖ |
| ISSN | 2181-9300 |
| Nashr sanasi | 2022-05-31 |
| Jild | 7 |
| Son | 2 |
| Til | Ingliz |
| Ilmiy soha | Tibbiyot |
| Indeksga qo‘shilgan | 2026-08-27 |
противоопуопухолевая активность, новый препарат К-2, Солидная опухоли Эрлиха АКАТОЛ, препараты сравнения, побочный эффект, antitumor activity, new drug K-2, Ehrlich solid tumor AKATOL, comparator drugs, side effect., o'smaga qarshi faollik, yangi K-2 preparati, Erlix solid o'smasi AKATOL, solishtirma dorilar, nojo'ya ta'sir
| APA | YULDASHEV Zhovlon Abduraim-ugly, ABDUKHALILOV Majid Mamatkulovich, RAKHIMOV Nodir Maxammatkulovich, ENIKEEVA Zulfiya Makhmudovna, & IBRAGIMOV Shavkat Narzikulovich (2022). STUDY OF THE ANTITUMOR ACTIVITY OF THE DRUG COLHAMETIN (K-2) ON 2 SOLID TUMORS OF MICE IN COMPARISON WITH A NUMBER OF CYTOSTATICS. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(2). https://tadqiqot.uz/index.php/biomedicine/article/view/4682 |
|---|---|
| GOST (OAK) | YULDASHEV Zhovlon Abduraim-ugly va b. STUDY OF THE ANTITUMOR ACTIVITY OF THE DRUG COLHAMETIN (K-2) ON 2 SOLID TUMORS OF MICE IN COMPARISON WITH A NUMBER OF CYTOSTATICS // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. – 2022. – T. 7, № 2. |
| MLA | YULDASHEV Zhovlon Abduraim-ugly, ABDUKHALILOV Majid Mamatkulovich, RAKHIMOV Nodir Maxammatkulovich, ENIKEEVA Zulfiya Makhmudovna, and IBRAGIMOV Shavkat Narzikulovich. “STUDY OF THE ANTITUMOR ACTIVITY OF THE DRUG COLHAMETIN (K-2) ON 2 SOLID TUMORS OF MICE IN COMPARISON WITH A NUMBER OF CYTOSTATICS.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(2), 2022. https://tadqiqot.uz/index.php/biomedicine/article/view/4682 |
| Chicago | YULDASHEV Zhovlon Abduraim-ugly, ABDUKHALILOV Majid Mamatkulovich, RAKHIMOV Nodir Maxammatkulovich, ENIKEEVA Zulfiya Makhmudovna, and IBRAGIMOV Shavkat Narzikulovich. “STUDY OF THE ANTITUMOR ACTIVITY OF THE DRUG COLHAMETIN (K-2) ON 2 SOLID TUMORS OF MICE IN COMPARISON WITH A NUMBER OF CYTOSTATICS.” Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(2) (2022). https://tadqiqot.uz/index.php/biomedicine/article/view/4682 |
| Harvard | YULDASHEV Zhovlon Abduraim-ugly, ABDUKHALILOV Majid Mamatkulovich, RAKHIMOV Nodir Maxammatkulovich, ENIKEEVA Zulfiya Makhmudovna, and IBRAGIMOV Shavkat Narzikulovich (2022) ‘STUDY OF THE ANTITUMOR ACTIVITY OF THE DRUG COLHAMETIN (K-2) ON 2 SOLID TUMORS OF MICE IN COMPARISON WITH A NUMBER OF CYTOSTATICS’, Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 7(2). https://tadqiqot.uz/index.php/biomedicine/article/view/4682 |
| BibTeX | @article{yuldashevzhovlonabduraimugly2022,
title = {STUDY OF THE ANTITUMOR ACTIVITY OF THE DRUG COLHAMETIN (K-2) ON 2 SOLID TUMORS OF MICE IN COMPARISON WITH A NUMBER OF CYTOSTATICS},
author = {YULDASHEV Zhovlon Abduraim-ugly and ABDUKHALILOV Majid Mamatkulovich and RAKHIMOV Nodir Maxammatkulovich and ENIKEEVA Zulfiya Makhmudovna and IBRAGIMOV Shavkat Narzikulovich},
journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
year = {2022},
volume = {7},
number = {2},
url = {https://tadqiqot.uz/index.php/biomedicine/article/view/4682}
} |
Boshqa maqola uchun iqtibos tayyorlash
Purpose: to study the features of psychopathological and vegetative disorders in 82 patients with chronic pain syndrome in dorsopathy of compression-ischemic origin. Methods: in patients with chronic pain syndrome with…
Purpose of work: To improve the result of surgical treatment of locally advanced gastric cancer by using palliative resection and gastrectomy. In the study, pancreatic involvement was observed in 91.2% of cases in T4…
A study of the Fergana Valley showed that by the end of 2020, the registration of cancer patients was 26,405 people with malignant neoplasms. The highest prevalence of malignant neoplasms was in the Namangan region…
Bladder cancer is the second most common tumor among all neoplasms of the genitourinary tract in the world. The most common is urothelial (transitional cell) RMP, which accounts for up to 90-95% of all bladder tumors…
Purpose: To improve the diagnosis of volumetric formations of the liver using radiation methods. Material and research methods. On the basis of the SВRSSPMCOR, we analyzed the results of PET-CT studies of patients for…
Aim: to study the clinical, radiological and computed tomography features of the myasthenic form of thymoma and thymoma with myasthenic syndrome. Materials and methods: 67 patients - 40 (59.7%) men and 27 (40.3%) women…
Purpose: Determination of a personal genotype of drug stability of cancer patients according to polymorphic marker 3435T MDR1 gene to predict individual chemotherapy regime. Methods: During the implementation of…
Damage to the inner ear can be a consequence of both acute and chronic diseases: infectious diseases, poisoning, stress, injuries, diseases of the cardiovascular system and many other conditions. The purpose of this…
Of 548 patients with complaints of vertigo due to ENT pathology, diseases of the cardiovascular and nervous systems, 101 (18,5±1,6%) had positional paroxysmal nystagmus (PPN). As a result of clinical and statistical…
In the development of rhinosinusitis, which occurs in patients treated with cerebral palsy from childhood, the mucociliary transport status of the nasal mucosa is important. Disruption of this function of the mucous…
Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar · 2022-yil arxivi
Настоящее исследование посвящено разработке алгоритма раннего выявления сенсоневральной тугоухости у детей с использованием методов полимеразной цепной реакции (ПЦР). Обследовано 235 детей с нарушениями слуха, из…
В статье представлены клинические аспекты и диагностические проблемы выявления сенсоневральной тугоухости у новорождённых с перинатальной патологией. Обследовано 115 новорождённых, из которых 35 перенесли асфиксию, а у…
Сенсоневральная тугоухость (СНТ) у детей остаётся одной из наиболее актуальных проблем современной оториноларингологии и медицинской генетики. Ранняя диагностика нарушений слуха играет ключевую роль в предупреждении…
Сенсоневральная тугоухость у новорождённых является одной из ведущих причин нарушения слухоречевого развития и ранней инвалидизации. Наиболее уязвимыми считаются дети, перенёсшие перинатальные осложнения, такие как…
Mazkur eksperimental tadqiqotda yuqori yog‘li ratsion va seftriaksonning lipid hamda uglevod almashinuviga alohida va birgalikdagi ta’siri 160 ta oq zotsiz erkak kalamushda o‘rganildi. Tajriba hayvonlari to‘rtta guruhga…
Мазкур тадқиқотда Тошкет вилоятидаги Ўрта Чирчиқ тумани 25-сонли, Бўка тумани 3-сонли ва 9-сонли давлат мактабгача таълим ташкилотларида 2025 йил ёз мавсумидаги таомномаларнинг озиқ-овқат маҳсулотлари билан…